| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |